Reversible pancytopenia secondary to treatment with tetrathiomolybdate.
D000328:Adult; D005260:Female; D006527:Hepatolenticular Degeneration / Q000188:drug therapy; D006801:Humans; D008297:Male; D008982:Molybdenum / Q000009:adverse effects*; D010198:Pancytopenia / Q000139:chemically induced*
D008982:Molybdenum; C020809:tetrathiomolybdate